Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000630546 | SCV000751509 | likely benign | Duchenne muscular dystrophy | 2024-11-11 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002504994 | SCV002814943 | uncertain significance | Becker muscular dystrophy; Duchenne muscular dystrophy; Dilated cardiomyopathy 3B | 2022-03-07 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV003144127 | SCV003829508 | uncertain significance | not provided | 2022-09-27 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003162512 | SCV003868344 | uncertain significance | Cardiovascular phenotype | 2023-01-27 | criteria provided, single submitter | clinical testing | The p.L2800S variant (also known as c.8399T>C), located in coding exon 57 of the DMD gene, results from a T to C substitution at nucleotide position 8399. The leucine at codon 2800 is replaced by serine, an amino acid with dissimilar properties. Based on data from gnomAD, the C allele has an overall frequency of <0.01% (14/173249) total alleles studied, with 1 hemizygote observed. The highest observed frequency was 0.05% (14/26643) of Latino alleles. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Natera, |
RCV001826763 | SCV002087678 | uncertain significance | Becker muscular dystrophy; Duchenne muscular dystrophy; Cardiomyopathy; Dystrophin deficiency | 2018-04-27 | no assertion criteria provided | clinical testing |